Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

360 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Prechemotherapy serum levels of CD105, transforming growth factor beta2, and vascular endothelial growth factor are associated with prognosis in patients with advanced epithelial ovarian cancer treated with cytoreductive surgery and platinum-based chemotherapy.
Bozas G, Terpos E, Gika D, Karadimou A, Dimopoulos MA, Bamias A. Bozas G, et al. Among authors: bamias a. Int J Gynecol Cancer. 2010 Feb;20(2):248-54. doi: 10.1111/IGC.0b013e3181cc25c3. Int J Gynecol Cancer. 2010. PMID: 20134268
Development and validation of a PCR-based assay for the selection of patients more likely to benefit from therapeutic treatment with alkylating drugs.
Stefanou DT, Episkopou H, Kyrtopoulos SA, Bamias A, Gkotzamanidou M, Bamia C, Liakou C, Bekyrou M, Sfikakis PP, Dimopoulos MA, Souliotis VL. Stefanou DT, et al. Among authors: bamias a. Br J Clin Pharmacol. 2012 Nov;74(5):842-53. doi: 10.1111/j.1365-2125.2012.04274.x. Br J Clin Pharmacol. 2012. PMID: 22432918 Free PMC article.
ERCC1 19007 Polymorphism in Greek Patients with Advanced Urothelial Cancer Treated with Platinum-Based Chemotherapy: Effect of the Changing Treatment Paradigm: A Cohort Study by the Hellenic GU Cancer Group.
Bamias A, Koutsoukos K, Gavalas N, Zakopoulou R, Tzannis K, Dedes N, Boulouta A, Fragkoulis C, Kostouros E, Dellis A, Mitsogiannis I, Adamakis I, Anastasiou I, Skolarikos A, Papatsoris A, Stravodimos K, Ferakis N, Pagoni S, Ntoumas K, Mitropoulos D, Deliveliotis C, Constantinides CA, Dimopoulos MA. Bamias A, et al. Curr Oncol. 2021 Nov 5;28(6):4474-4484. doi: 10.3390/curroncol28060380. Curr Oncol. 2021. PMID: 34898581 Free PMC article.
DNA Damage Repair: Predictor of Platinum Efficacy in Ovarian Cancer?
Stefanou DT, Souliotis VL, Zakopoulou R, Liontos M, Bamias A. Stefanou DT, et al. Among authors: bamias a. Biomedicines. 2021 Dec 31;10(1):82. doi: 10.3390/biomedicines10010082. Biomedicines. 2021. PMID: 35052761 Free PMC article. Review.
Chemotherapy response score as a predictor of survival in ovarian cancer patients.
Rodolakis I, Liontos M, Pergialiotis V, Haidopoulos D, Kaparelou M, Efthimios Vlachos D, Dimopoulos MA, Loutradis D, Rodolakis A, Bamias A, Thomakos N. Rodolakis I, et al. Among authors: bamias a. Eur J Obstet Gynecol Reprod Biol. 2024 May;296:233-238. doi: 10.1016/j.ejogrb.2024.03.003. Epub 2024 Mar 7. Eur J Obstet Gynecol Reprod Biol. 2024. PMID: 38479209
360 results